May 15, 2012
CORE Science Solutions (CSS) Consortia, the Academic Gastrointestinal Cancer Consortium (AGICC) and Academic Myeloma Consortium (AMyC) will have a presence at the 2012 ASCO meeting June 1-4 in Chicago, IL. The booth (#6062) will be hosted by both CSS and its parent company, Criterium, Inc. Please visit the booth and discover the innovative model of research designed to collaborate with pharmaceutical and biotech companies on the development of their early phase clinical studies in these diseases.
CSS and Criterium will also hold a meet and greet reception for its institutions, investigators, and current and future sponsors.
About AGICC and AMyC
The CSS GI Cancer Consortium and Myeloma Consortium provide expertise and innovative solutions for the rapid start-up and completion of complex cancer trials with translational endpoints. These consortia bring together the highest quality institutions and pharmaceutical sponsors to use the best possible data in the fastest way possible, to facilitate and speed the decision-making process in drug development.